Valuation: Cosmos Health Inc.

Market Cap 15.13M 13.23M 12.21M 11.22M 21.26M 1.46B 21.62M 146M 57.18M 712M 56.84M 55.59M 2.45B P/E 2026 *
27.9x
P/E 2027 * 3.98x
Enterprise Value 15.13M 13.23M 12.21M 11.22M 21.26M 1.46B 21.62M 146M 57.18M 712M 56.84M 55.59M 2.45B EV / Sales 2026 *
0.17x
EV / Sales 2027 * 0.14x
Free-Float
65.92%
Yield 2026 *
-
Yield 2027 * -
1 day-9.31%
1 week+5.53%
Current month+50.79%
1 month+17.46%
3 months-28.68%
6 months-48.60%
Current year-44.08%
1 week 0.24
Extreme 0.2449
0.35
1 month 0.16
Extreme 0.1616
0.35
Current year 0.16
Extreme 0.1616
0.59
1 year 0.16
Extreme 0.1616
1.32
3 years 0.16
Extreme 0.1616
3.08
5 years 0.16
Extreme 0.1616
150
10 years 0.16
Extreme 0.1616
312.5
Manager TitleAgeSince
Chief Executive Officer 60 2016-02-25
Director of Finance/CFO 43 2020-11-10
Chief Operating Officer 56 2023-01-31
Director TitleAgeSince
Director/Board Member 58 2014-01-12
Chairman 60 2016-02-25
Director/Board Member 59 2016-11-17
Date Insider Type Main position Quantity % Market Cap.
Jun. 15Buy

Chief Financial Officer

168,135 0.2708%
Jun. 10Buy

Chief Executive Officer

218,447 0.3519%
Jun. 09Buy

Chief Executive Officer

701,447 1.1299%
Change 5-day change 1-year change 3-year change Capi.($)
-9.31%+5.53%-38.12%-90.78% 15.13M
-0.87%-2.73%+12.03%+94.47% 93.23B
-2.25%-5.15%+39.70%+141.51% 52.68B
+0.34%+2.44%+6.91%+284.31% 23.59B
+1.57%+4.39%-11.21%-20.01% 8.34B
+4.98%+8.64%-22.55%-29.95% 8.14B
+2.06%+6.90%-3.83%-26.10% 6.95B
+0.29%-3.54%+21.09%+30.38% 6.11B
+0.46%+0.86%-0.62%+23.70% 5.39B
-0.96%+2.99%-4.44%-4.91% 3.8B
Average -0.37%+1.83%-0.11%+40.26% 20.82B
Weighted average by Cap. -0.59%-1.16%+15.27%+108.86%

Financials

2026 *2027 *
Net sales 87.3M 76.33M 70.41M 64.72M 123M 8.4B 125M 841M 330M 4.11B 328M 321M 14.15B 111M 96.87M 89.36M 82.15M 156M 10.66B 158M 1.07B 419M 5.21B 416M 407M 17.96B
Net income - -
Net Debt - -
Logo Cosmos Health Inc.
Cosmos Health Inc. is a diversified, vertically integrated global healthcare company. The Company owns a portfolio of proprietary pharmaceutical and nutraceutical brands, including Sky Premium Life, Mediterranation, bio-bebe, C-Sept and C-Scrub. Through its subsidiary Cana Laboratories S.A., it manufactures pharmaceuticals, food supplements, cosmetics, biocides, and medical devices within the European Union. It also distributes a broad line of pharmaceuticals and parapharmaceuticals, including branded generics and over-the-counter (OTC) medications, to retail pharmacies and wholesale distributors through its subsidiaries in Greece and the United Kingdom. It also has research and development (R&D) partnerships targeting health disorders such as obesity, diabetes, and cancer, enhanced by artificial intelligence drug repurposing technologies, and focuses on the R&D of patented nutraceuticals, specialized root extracts, proprietary complex generics, and OTC products.
Employees
163
Date Price Change Volume
26-07-15 $0.2785 -9.31% 5,659,626
26-07-14 $0.3071 -0.42% 7,118,171
26-07-13 $0.3084 +5.36% 15,850,182
26-07-10 $0.2927 +12.02% 22,345,760
26-07-09 $0.2613 -0.99% 5,050,678

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. COSM Stock